This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendFDA EventsHeadlinesOptions ChainTrendsBuy This Stock SVA vs. MIRM, RARE, APLS, IBRX, XENE, AGIO, ARWR, KNSA, TWST, and BEAMShould you be buying Sinovac Biotech stock or one of its competitors? The main competitors of Sinovac Biotech include Mirum Pharmaceuticals (MIRM), Ultragenyx Pharmaceutical (RARE), Apellis Pharmaceuticals (APLS), ImmunityBio (IBRX), Xenon Pharmaceuticals (XENE), Agios Pharmaceuticals (AGIO), Arrowhead Pharmaceuticals (ARWR), Kiniksa Pharmaceuticals International (KNSA), Twist Bioscience (TWST), and Beam Therapeutics (BEAM). These companies are all part of the "med - biomed/gene" industry. Sinovac Biotech vs. Its Competitors Mirum Pharmaceuticals Ultragenyx Pharmaceutical Apellis Pharmaceuticals ImmunityBio Xenon Pharmaceuticals Agios Pharmaceuticals Arrowhead Pharmaceuticals Kiniksa Pharmaceuticals International Twist Bioscience Beam Therapeutics Mirum Pharmaceuticals (NASDAQ:MIRM) and Sinovac Biotech (NASDAQ:SVA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Is MIRM or SVA more profitable? Sinovac Biotech has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -20.39%. Sinovac Biotech's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mirum Pharmaceuticals-20.39% -33.63% -11.50% Sinovac Biotech N/A N/A N/A Do analysts rate MIRM or SVA? Mirum Pharmaceuticals currently has a consensus target price of $65.50, suggesting a potential upside of 26.37%. Given Mirum Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Mirum Pharmaceuticals is more favorable than Sinovac Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Sinovac Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, MIRM or SVA? Mirum Pharmaceuticals has higher earnings, but lower revenue than Sinovac Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMirum Pharmaceuticals$336.89M7.62-$87.94M-$1.61-32.19Sinovac Biotech$448.27M1.44-$99.92MN/AN/A Which has more risk & volatility, MIRM or SVA? Mirum Pharmaceuticals has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Sinovac Biotech has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Does the media refer more to MIRM or SVA? In the previous week, Mirum Pharmaceuticals had 2 more articles in the media than Sinovac Biotech. MarketBeat recorded 3 mentions for Mirum Pharmaceuticals and 1 mentions for Sinovac Biotech. Mirum Pharmaceuticals' average media sentiment score of 1.80 beat Sinovac Biotech's score of 0.00 indicating that Mirum Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Mirum Pharmaceuticals Very Positive Sinovac Biotech Neutral SummaryMirum Pharmaceuticals beats Sinovac Biotech on 9 of the 13 factors compared between the two stocks. Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSinovac BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$644.66M$3.05B$5.72B$9.53BDividend YieldN/A2.36%4.69%4.01%P/E RatioN/A21.3228.4120.07Price / Sales1.44211.43391.5070.34Price / Cash38.9542.6036.1858.54Price / Book0.058.328.655.87Net Income-$99.92M-$55.19M$3.25B$258.89M Sinovac Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASinovac BiotechN/A$6.47flatN/AN/A$644.66M$448.27M0.003,261High Trading VolumeMIRMMirum Pharmaceuticals3.8647 of 5 stars$51.95+0.0%$65.50+26.1%+19.6%$2.57B$336.89M-32.27140RAREUltragenyx Pharmaceutical4.4172 of 5 stars$26.39+0.3%$83.64+216.9%-39.1%$2.49B$590.69M-4.491,294Upcoming EarningsHigh Trading VolumeAPLSApellis Pharmaceuticals4.1832 of 5 stars$19.28-1.0%$40.00+107.5%-50.7%$2.45B$781.37M-10.77770Upcoming EarningsIBRXImmunityBio2.1215 of 5 stars$2.68-2.5%$12.25+357.1%-49.0%$2.43B$14.74M-4.62590News CoverageAnalyst ForecastXENEXenon Pharmaceuticals3.7464 of 5 stars$31.49-0.3%$54.82+74.1%-31.1%$2.42B$7.50M-9.75210Positive NewsOptions VolumeAGIOAgios Pharmaceuticals4.3506 of 5 stars$39.92-0.2%$58.60+46.8%-16.8%$2.32B$36.50M3.55390Upcoming EarningsAnalyst ForecastARWRArrowhead Pharmaceuticals3.797 of 5 stars$14.71-12.2%$43.71+197.2%-44.2%$2.31B$3.55M-10.51400News CoverageHigh Trading VolumeKNSAKiniksa Pharmaceuticals International3.4398 of 5 stars$28.42-2.1%$39.67+39.6%+0.8%$2.12B$423.24M-113.68220News CoverageTWSTTwist Bioscience4.4358 of 5 stars$34.77-1.1%$50.40+45.0%-38.0%$2.11B$312.97M-10.70990News CoveragePositive NewsBEAMBeam Therapeutics2.2698 of 5 stars$21.03+1.3%$48.75+131.8%-34.5%$2.09B$63.52M-4.56510Analyst Revision Related Companies and Tools Related Companies MIRM Alternatives RARE Alternatives APLS Alternatives IBRX Alternatives XENE Alternatives AGIO Alternatives ARWR Alternatives KNSA Alternatives TWST Alternatives BEAM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SVA) was last updated on 7/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
